The Motley Fool Unveils Top Biotech Stock Picks for 2026 ACCO Q1 2026 Earnings EPS Surprise Drives Cautious Optimism Amid Modest Stock Decline Gold Pressures Persist as Trumps Iran Deal Push Raises Supply Hopes